Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Toyohara J, Al-Qahtani M, Huang YY, Cazzola E, Todde S, Furumoto S, Mikolajczak R, Decristoforo C, Gillings N, Yang M, Reilly R, Duatti A, Denkova A, Schirrmacher R, Carlucci G, Seimbille Y, Liu Z, Ellis B, Cornelissen BT, Kopka K, Bernardes E. Toyohara J, et al. Among authors: mikolajczak r. EJNMMI Radiopharm Chem. 2022 Oct 1;7(1):25. doi: 10.1186/s41181-022-00177-w. EJNMMI Radiopharm Chem. 2022. PMID: 36182995 Free PMC article. Review.
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
Elsinga P, Todde S, Penuelas I, Meyer G, Farstad B, Faivre-Chauvet A, Mikolajczak R, Westera G, Gmeiner-Stopar T, Decristoforo C; Radiopharmacy Committee of the EANM. Elsinga P, et al. Among authors: mikolajczak r. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1049-62. doi: 10.1007/s00259-010-1407-3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20306035 Free PMC article.
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients.
Maina T, Konijnenberg MW, KolencPeitl P, Garnuszek P, Nock BA, Kaloudi A, Kroselj M, Zaletel K, Maecke H, Mansi R, Erba P, von Guggenberg E, Hubalewska-Dydejczyk A, Mikolajczak R, Decristoforo C. Maina T, et al. Among authors: mikolajczak r. Eur J Pharm Sci. 2016 Aug 25;91:236-42. doi: 10.1016/j.ejps.2016.05.011. Epub 2016 May 14. Eur J Pharm Sci. 2016. PMID: 27185299 Free PMC article.
Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates.
Fani M, Weingaertner V, Kolenc Peitl P, Mansi R, Gaonkar RH, Garnuszek P, Mikolajczak R, Novak D, Simoncic U, Hubalewska-Dydejczyk A, Rangger C, Kaeopookum P, Decristoforo C. Fani M, et al. Among authors: mikolajczak r. Pharmaceuticals (Basel). 2020 Dec 28;14(1):19. doi: 10.3390/ph14010019. Pharmaceuticals (Basel). 2020. PMID: 33379299 Free PMC article.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Alves F, Antunes IF, Cazzola E, Cleeren F, Cornelissen B, Denkova A, Engle J, Faivre-Chauvet A, Gillings N, Hendrikx JJMA, Jalilian AR, van der Meulen NP, Mikolajczak R, Neels OC, Pillai MRA, Reilly R, Rubow S, Seimbille Y, Spreckelmeyer S, Szymanski W, Taddei C. Alves F, et al. Among authors: mikolajczak r. EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9. EJNMMI Radiopharm Chem. 2021. PMID: 34495412 Free PMC article. Review.
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.
Korde A, Mikolajczak R, Kolenc P, Bouziotis P, Westin H, Lauritzen M, Koole M, Herth MM, Bardiès M, Martins AF, Paulo A, Lyashchenko SK, Todde S, Nag S, Lamprou E, Abrunhosa A, Giammarile F, Decristoforo C. Korde A, et al. Among authors: mikolajczak r. EJNMMI Radiopharm Chem. 2022 Jul 19;7(1):18. doi: 10.1186/s41181-022-00168-x. EJNMMI Radiopharm Chem. 2022. PMID: 35852679 Free PMC article. Review.
107 results